United States & Canada Cold Chain Packaging Market is Growing at a Strong CAGR of 12.2% by 2033 | FMI

The market for cold chain packaging in the United States and Canada is anticipated to reach a value of USD 6.9 Billion in 2023. From 2023 to 2033, it is expected to expand at a CAGR of 12.2%. By the end of 2033, it is projected to have a value of USD 21.8 Billion.

By 2023, it is expected that the top 5 producers of cold chain packaging in the United States and Canada would account for 10% to 15% of the whole market. Cold chain packaging is predicted to become increasingly popular in the meat, poultry, and seafood industries, as well as in the baking and confectionery sectors.

Increasing demand for more suitable shipping of temperature-sensitive pharmaceutical products resulted in advanced research for improved cold chain packaging insulation solutions. One of these includes vacuum-insulated packaging (VIP).

Get the Complete Story—Read More About Our Latest Report!

Vacuum-insulated packaging delivers key benefits over polyurethane and expanded polystyrene-based insulated shippers. VIP-based shippers are comparatively lighter and smaller in weight.

These help to reduce refrigerant requirements, provide a broad temperature range, and successively cut down distribution costs. CSafe, one of the prominent producers of VIP, incorporates its exclusive ‘ThermoCor’ VIP combined with a protective buffer.

It offers shippers at a cost lower than conventional PUR shippers. Increasing preference for ocean freight often expands carriage time. It is anticipated to further drive the adoption of VIP-based shippers.

Sonoco Thermosafe’s product Greenbox, for instance, is for the pharmaceutical industry. It employs VIP for insulation and has a patented renewable phase change material that is plant-based. Sofrigam’s elite cooling boxes incorporate PUR and VIP and offer temperature stability up to 240 hours.

Key Takeaways:

  • The polymer segment by material type is likely to hold around USD 15.2 Billion of the market value in 2033.
  • The paper segment is estimated to witness a gain of 2.1x times by value and a CAGR of 14.2% during the forecast period.
  • The gel packs segment by product type is anticipated to witness a 12.6% CAGR from 2023 to 2033.
  • Phase change cold storage products segment is estimated to witness a gain of 3.8 times its value by the end of 2033.
  • The reusable packaging segment by packaging format is anticipated to witness a CAGR of 12.7% in the assessment period.

“Reusable and disposable packaging options are provided by companies in both countries’ cold chain packaging markets. Manufacturers in the sector would also make key investments in research & development to make more affordable and temperature-efficient systems.” – Comments a lead analyst at FMI.

Advanced Technology for Enhancing Safety and Temperature Monitoring to Drive Sales:

One prominent area where passive packaging lacks behind active packaging is its tenuous ability to provide safety during transportation. Numerous companies are offering shippers equipped with temperature sensors, which immediately detect if the container has been opened during transportation.

A few shippers now come equipped with thermochromic labels that change color to provide visual verification that shippers are ready to pack. Pelican’s reusable shipper and Sofrigam’s Elite cooling box, for instance, come equipped with these sensors.

Data loggers with temperature sensors and USB connection points are becoming highly common and inexpensive to integrate. These label-like loggers effortlessly attach to the packaging, continually follow temperature conditions, and supply a comprehensive study for time & temperature data.

Battery-powered data loggers can include developed technologies such as WiFi, RFID, and GPS. It can deliver real-time details about temperature fluctuations. A few of the product offerings include BIOmed Xpress PDF, PakSense, and temperature monitoring LabelCCL100, cold chain logger, Tempt RIP, and Vaisala.

Competitive Landscape:

Leading companies in the cold chain packaging business in the United States and Canada are making significant gains by creating innovative products. They would also benefit from recent initiatives and mergers made by well-known Canada- and United States-based players to obtain a competitive edge.

Key Companies Profiled in the United States & Canada Cold Chain Packaging Market are Sonoco Products Company, Sofrigam SAS, Cryopak Industries Inc., CSafe Global, LLC, DGP Intelsius LLC, TemperPack Technologies, Inc., Engineered Packaging, Inc. dba Chill-Pak, American Thermal Instruments, Mettcover Global, Nordic Cold Chain Solutions, RipplePak Ltd., Insulated Products Corporation, Klinge Corporation, Sealed Air Corporation, Cold Chain Technologies, Orora Packaging Solutions, Envirotainer AB, Emball’iso Inc, SÆPLAST AMERICAS INC., Atlas Molded Products (Atlas Roofing Corporation), Cascades Inc., Pelican Products, Inc.

For instance,

  • In May 2021, CSafe developed a VIP insulated shipper for BioNTech’s facility. It provides 10+ days of temperature protection for vaccine shipments with minimal dry ice.

United States & Canada Cold Chain Packaging Market Outlook by Category

By Product Type:

  • Pallet Shippers
  • Insulated Containers
  • Foam Bricks
  • Gel Packs
  • Protective Packaging
  • Phase Change Cold Storage Products

By Material Type:

  • Polymer
    • Polyethylene
    • Polypropylene
    • PET
    • EPS
    • Polyurethane
    • Others (PVC, Nylon, Teflon)
  • Metal
  • Paper

By Packaging Formats:

  • Reusable Packaging
  • Disposable Packaging

By End Use:

  • Food
  • Beverages
  • Pharmaceutical
  • Cosmetics & Personal Care
  • Chemical
  • Others (Textile, Electronics, Research Institutes, Building & Construction)

By Country:

  • United States
  • Canada

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

What is a Liquid Diet Regimen: A Comprehensive Guide

A fluid diet is a kind of consuming strategy that forte uromexil involves consuming just liquids and staying clear of solid foods. This can consist of numerous beverages, shakes, soups, and also other fluids that offer crucial nutrients to the body. While fluid diets are usually utilized for medical purposes, they can additionally be adhered to for weight loss or as part of a detoxification program. In this post, we will certainly check out the different kinds of fluid diets, their advantages and threats, and also how to follow them securely.

Sorts Of Liquid Diet Plans

There are a number of types of liquid diet plans, each with its own particular guidelines and also purposes:

1. Clear Fluid Diet:

A clear liquid diet regimen consists of transparent liquids that are very easy to absorb as well as leave little deposit in the intestinal system. This sort of diet regimen is often advised before or after surgery, during particular medical treatments, or if you are experiencing digestive system concerns. Common instances of clear liquids consist of water, broth, gelatin, clear fruit juices, and also tea or coffee without milk or lotion.

2. Full Fluid Diet Plan:

A complete fluid diet consists of all the beverages allowed in a clear liquid diet plan, along with foods that are fluid at area temperature or can be easily blended. This diet may be advised for people recovering from surgical treatment or health problem, as it supplies more calories and also nutrients. Examples of foods allowed on a complete fluid diet consist of milk, yogurt, fruit juices with pulp, cream soups, and also healthy protein shakes.

3. Modified Fluid Diet:

A customized fluid diet regimen is customized to meet specific nutritional requirements based on specific health and wellness problems. It may entail leaving out certain types of fluids or incorporating added supplements or medications. This type of diet is frequently suggested for individuals with clinical problems such as diabetes mellitus, kidney illness, or ingesting difficulties.

4. Meal Replacement Trembles:

Meal replacement drinks are readily offered liquid products that are designed to replace one or more dishes per day. These shakes typically supply a well balanced amount of nutrients, including proteins, carbs, fats, vitamins, and minerals. They can be an efficient tool for weight reduction or ease, but it is important to select high-grade products as well as speak with a medical care expert prior to utilizing them as a long-lasting meal substitute.

  • 5. Juice Cleans:

Juice cleanses entail eating just fresh vegetables and fruit juices for a marked duration, normally ranging from a couple of days to a couple of weeks. Proponents of juice cleanses insurance claim that they help purify the body, improve digestion, as well as promote fat burning. Nevertheless, it is important to note that juice cleanses lack important nutrients like fiber as well as protein, and they may not appropriate for everyone. It is recommended to talk to a healthcare expert before starting a juice clean.

Benefits of a Liquid Diet

Liquid diet plans can provide several advantages depending on individual goals and wellness conditions:

1. Fat burning:

Lots of people transform to fluid diet regimens to jump-start their weight reduction trip. By eliminating solid foods and decreasing calorie consumption, fluid diets can bring about first quick weight management. However, it is very important to remember that lasting weight reduction calls for a well balanced, lasting method that consists of healthy eating routines and regular exercise.

2. Medical Factors:

Fluid diets are commonly prescribed by health care professionals for clinical reasons. As an example, they might be suggested prior to surgical procedure to decrease the risk of difficulties or to prepare the digestive system for certain medical tests. Liquid diet regimens can additionally be used to take care of details clinical conditions, such as Crohn’s illness or cranky bowel disorder (IBS).

3. Digestion Relax:

For individuals with digestive system concerns or those recovering from gastrointestinal surgery, a fluid diet can provide remainder to the digestive system. By taking in easily absorbable fluids, the digestive system organs require much less effort to damage down food, permitting them to heal and also recover.

Dangers and Safety measures

While liquid diet plans can be useful in particular situations, they additionally come with prospective threats and also preventative measures:

1. Nutrient Deficiency:

Depending upon the type and also period of the fluid diet plan, there is a threat of nutrient shortages. Strong foods give important nutrients like fiber, protein, vitamins, and minerals that might be lacking in a fluid diet regimen. It is essential to ensure that the picked fluids are nutritionally balanced or to seek advice from a health care professional depanten na stawy apteka for proper supplementation.

2. Muscle Loss:

Extreme or long term liquid diets can lead to muscle loss, as they typically do not have sufficient healthy protein. Protein is crucial for preserving muscular tissue mass, supporting immune feature, and also promoting overall health and wellness. It is vital to consist of protein resources in a fluid diet regimen or consider protein supplementation.

3. Unsustainable Weight-loss:

While liquid diet plans can result in preliminary weight-loss, they are usually not sustainable in the long-term. The restriction of solid foods can be testing to maintain, and also the quick weight-loss frequently causes weight reclaim when typical eating patterns are resumed. It is important to concentrate on healthy, well balanced consuming routines for sustainable weight management.

In Conclusion

Liquid diets can serve different functions, consisting of weight loss, medical reasons, or gastrointestinal remainder. They come in different forms, such as clear fluid, complete fluid, modified liquid, meal replacement drinks, or juice cleanses. While they can offer benefits in specific circumstances, it is necessary to consider the possible risks as well as precautions associated with this sort of eating strategy. It is constantly recommended to seek advice from a health care expert before starting a liquid diet to ensure it appropriates for your specific demands and also goals.

Bear in mind, sustainable and also lasting health and wellness is best achieved via a balanced and also varied diet regimen that consists of whole foods and also is matched by regular physical activity.

Global Cerebral Vein Thrombosis Treatment Industry Expected to Reach USD 611 Million by 2033

The global cerebral vein thrombosis treatment industry, valued at USD 191.53 million in 2023, is set to witness a substantial growth trajectory with a projected Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period from 2023 to 2033. By the end of 2033, the market is anticipated to soar to an estimated value of USD 611 million. This surge is attributed to the confluence of technological advancements in medical interventions, a growing prevalence of CVT (Cerebral Vein Thrombosis), especially among younger demographics, and an upsurge in healthcare expenditure globally.

CVT, a relatively uncommon form of stroke, is progressively impacting a broader demographic, particularly women and individuals below the age of 50. According to the National Institute of Neurological Disorders and Stroke (NINDS), CVT affects 3 to 4 individuals per million annually. The escalating incidence of CVT has accentuated the demand for efficacious treatment solutions on a global scale.

As the incidence of CVT rises, so does the urgency for innovative treatment modalities. The market’s upward trajectory underscores a critical need for continued research, development, and investment in novel therapies to address the evolving healthcare landscape.

The anticipated growth of the global cerebral vein thrombosis treatment industry not only signifies a promising outlook for patients but also presents significant opportunities for stakeholders across the healthcare spectrum. With a focus on advancing medical technologies and enhancing accessibility to effective treatment options, the healthcare industry is poised to make profound strides in combating CVT and improving patient outcomes worldwide.

Key Takeaways from the Market Study:

  • The global cerebral vein thrombosis treatment industry is expected to grow with a 12.3% CAGR during 2023 to 2033.
  • By end use, hospitals and clinics are expected to hold 46% of the market share in 2023 for cerebral vein thrombosis treatment industry.
  • North America is expected to possess 44% market share for cerebral vein thrombosis treatment industry in 2023.
  • Europe Cerebral vein thrombosis treatment industry size is expected to possess 41% market share in 2023.

“Availability of effective and safe drug therapies is expected to drive the growth of the CVT treatment industry in the upcoming years.” states an FMI analyst

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Competitive Landscape:

Key players in the cerebral vein thrombosis treatment industry are Boston Scientific Corporation, AngioDynamics, Cardinal Health, Daesung Maref, Johnson & Johnson Services, Inc., Neuland Laboratories Ltd, Glenmark Pharmaceuticals Inc., Momenta Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation and Portola Pharmaceuticals, Inc.

  • Boston Scientific Corporation is involved in clinical research related to CVT. The company has conducted clinical trials to evaluate the safety and efficacy of its Vici Venous Stent System in the treatment of deep vein obstruction.
  • AngioDynamics’ key product for CVT treatment is BioFlo PICC, which is a peripherally inserted central catheter (PICC) that is coated with a proprietary Endexo technology. This coating has been shown to reduce the risk of catheter-related thrombosis, which can be a complication of CVT.

Key Segments Profiled in the Cerebral Vein Thrombosis Treatment Industry Survey:

Treatment:

  • Thrombolytic Therapy
  • Anticonvulsant Therapy

Drug Class:

  • Thalidomide
  • Tamoxifen
  • Phytoestrogens
  • L-asparaginase

End Use:

  • Hospitals & Clinics
  • Laboratories

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Autoimmune Disease Testing Industry Poised for Remarkable Growth, Set to reach USD 15.75 billion by 2033

According to Future Market Insights (FMI), the global autoimmune disease testing industry is on a trajectory of robust growth. Estimated at USD 6.07 billion in 2023, the market is projected to expand at a 10% compound annual growth rate (CAGR), reaching an impressive USD 15.75 billion by 2033.

This growth is driven by an alarming rise in the prevalence of autoimmune disorders such as rheumatoid arthritis, lupus, and multiple sclerosis, creating an urgent need for accurate and reliable diagnostic solutions. Early detection remains pivotal in managing these conditions effectively, spurring demand for innovative testing technologies.

Advancements in Diagnostic Technologies:

Technological breakthroughs in diagnostic methods, including novel biomarkers and cutting-edge testing techniques, are significantly bolstering market expansion. These advancements provide fast, precise, and cost-effective solutions, gaining widespread adoption among healthcare professionals and patients alike.

Public Awareness and Early Diagnosis:

The increasing public awareness of autoimmune diseases, coupled with initiatives by healthcare organizations, has highlighted the importance of early diagnosis. Patients are increasingly seeking rapid testing solutions to identify autoimmune conditions at an earlier stage, enhancing outcomes and reducing long-term healthcare burdens.

Growing Investments in Healthcare Infrastructure:

Increased healthcare spending, particularly in emerging economies, is another key factor driving market growth. Governments and healthcare organizations are investing heavily in enhancing healthcare infrastructure and improving access to diagnostic services. This has fueled the demand for autoimmune disease testing, ensuring a broader reach to underserved populations.

Rise of Point-of-Care Testing:

The adoption of point-of-care testing for autoimmune diseases is transforming the diagnostic landscape. By enabling quick and convenient tests at the patient’s bedside or in remote locations, these innovations eliminate the reliance on laboratory-based testing, delivering faster results and improving patient outcomes.

Opportunities in Developing Nations:

The expansion of healthcare facilities in developing countries presents a significant growth opportunity. As healthcare services become more accessible, the demand for autoimmune disease testing continues to rise, addressing the needs of a growing patient population.

The autoimmune disease testing industry stands at the forefront of diagnostic innovation, addressing a critical global health challenge. As advancements in technology and public health initiatives continue to evolve, the market is poised to experience unprecedented growth over the next decade.

Key Takeaways:

  • The autoimmune disease testing industry in the United States is growing significantly, driven by the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.
  • The autoimmune disease testing industry in the United Kingdom is experiencing growth due to the rising prevalence of autoimmune diseases which is driving demand for accurate and efficient testing methods.
  • The autoimmune disease testing industry in China is notably expanding, propelled by the growing population, changing lifestyles, and increased awareness about autoimmune diseases.
  • The reagents and consumables segment holds a dominant position in the autoimmune disease testing industry as it serves as a critical component in the diagnostic process.
  • The C-Reactive Protein (CRP) segment continues to dominate the autoimmune disease testing industry, driven by its high sensitivity and specificity in detecting inflammation and infection.

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Competitive Landscape:

The development of novel and precise diagnostic tests for autoimmune disorders is a top priority for manufacturers. To increase the sensitivity and specificity of tests, they are investing in cutting-edge technologies including point-of-care testing, molecular diagnostics, and immunoassays.

By releasing new autoimmune disease testing kits and platforms, manufacturers are also concentrating on diversifying their product lines. To take advantage of resources and skills that complement one another, they are also forging strategic partnerships with other businesses, research institutes, and laboratories. These alliances are designed to hasten the creation and distribution of innovative tests for autoimmune diseases.

Key Players:

  1. Hoffmann-La Roche Ltd, ZEUS Scientific, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Abbott, SQI Diagnostics Inc., Werfen, Trinity Biotech, KSL Beutner Laboratories (Beutner), Bio-Rad Laboratories, Inc. and others.

Recent Developments:

  • The United States Food and Drug Administration granted Werfen 501(K) clearance in June 2021 for the Aptiva Celiac Disease IgA and IgG tests. Also, the Aptiva CTD (connective tissue disease) essential panel was given the CE mark by the firm.
  • The Vectra test report had a significant upgrade in February 2021 by Myriad Genetics Inc. A unique assessment of a patient’s one-year risk of fast radiographic development is provided in the new test result (RP). According to the patient’s age, gender, and adiposity, the RP result is unique to each report.

Autoimmune Disease Testing industry Segmentation:

Autoimmune Disease Testing Industry By Product Type:

  • Instruments
  • Reagents & Consumables

Autoimmune Disease Testing Industry By Disease Type:

  • Rheumatoid Arthritis (RA)
  • Systemic Lupus Erythematosus (SLE)
  • Scleroderma
  • Vasculitis
  • Inflammatory Bowel Disease (IBD)
  • Others

Autoimmune Disease Testing Industry By Test Type:

  • Antinuclear Autoantibody (ANA)
  • Rheumatoid Factor (RF)
  • C-Reactive Protein (CRP)
  • Anti-Thyroglobulin Antibody (ATA)
  • Others

Autoimmune Disease Testing Industry By End User:

  • Hospital & Clinics
  • Diagnostic Centers
  • Others

Autoimmune Disease Testing Industry By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Central Nervous System Lymphoma Treatment Industry to reach USD $ 205.3 Billion by 2033; Growing at a 5.2% CAGR: FMI Study

According to Future Market Insights, the central nervous system lymphoma treatment industry is projected to rise at a steady growth valued at USD 123.2 billion with a 5.2% CAGR until 2033, being valued at USD 205.3 billion.

The rapid advancements in diagnostics and therapeutics of the central nervous system (CNS) disease significantly contribute to market growth. The rising prevalence of central nervous system diseases positively influences the market growth. The rising demand for effective therapeutic options catalyzes market growth.

Pharmaceutical companies are focusing on investing in and developing novel therapies for the treatment of CNS diseases. The surging approval of generic products and the entry of new products into the market favor market growth. The extensive R&D efforts, the introduction of novel drug-delivery systems, and the advancements in the drug-delivery systems bolster the market growth. The introduction of transdermal patches and the presence of strong pipeline products fuels the market growth. The key pharmaceutical players are focusing on treatments to prevent neurological disorders. The increasing awareness regarding mental health drives market growth. The rising awareness regarding neurodegenerative diseases by government and non-government organizations drives market growth.

The process of approval of central nervous system therapeutic and the drugs used to treat central nervous system diseases is very time-consuming. This factor restricts the market growth. Furthermore, research and development require a higher amount of investment which hampers market growth. It is a longer developmental and approval process. The higher cost per approval impedes the central nervous system therapeutic market growth.

The increasing prevalence of neurological disorders offers numerous opportunities for market growth. The rising diagnosis rates in developed and emerging countries significantly contribute to market growth. The governments are focusing on creating awareness regarding these conditions through campaigns. The launch of a new generation of antipsychotic drugs offers lucrative opportunities for market growth.

The innovation of central nervous system treatment drugs and strategic initiatives adopted by key companies operating in the CNS therapeutics market fuels the market growth. The increase in the prevalence and incidence of neurological disorders catalyzes market growth. The growing geriatric population and the growing product launches for treating neurological disorders propel the market growth.

The stringent regulations of the governments challenge the central nervous system therapeutic market growth. The therapeutic drugs used to treat the central nervous system must go through an approval process. This process is very strict, and various stringent regulations are imposed by the government, which further challenges market growth.

Key Takeaways from the Market Study:

  • The extensive R&D efforts, the introduction of novel drug-delivery systems, and the advancements in the drug-delivery systems bolster the market growth.
  • Process of approval of central nervous system therapeutic and the drugs used to treat central nervous system diseases is very time-consuming, thus restricting the market growth.
  • Innovation of central nervous system treatment drugs and strategic initiatives adopted by key companies operating in the CNS therapeutics market fuels the market growth.
  • Therapeutic drugs being used in the treatment of the central nervous system must go through an approval process where these stringent regulations of the governments have been imposed as a challenge to the central nervous system therapeutic market growth.

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Competitive Landscape:

Key players operating in the central nervous system lymphoma market include:

  • Amgen
  • Dr. Reddy’s laboratories
  • Roche
  • Bristol-Myers Squibb
  • Cipla
  • Merck
  • Novartis
  • AbbVie
  • Fresenius SE & Co. KGaA
  • Sanofi S.A

Some of the important developments of the key players in the market are:

  • In September 2020, Australia-based oncology-focused biotechnology company, Kazia Therapeutics Limited entered into collaboration with US-based Dana-Farber Cancer Institute. This collaboration aimed to investigate the use of paxalisib, a new investigational drug by Kazia Therapeutics in the treatment of the Central Nervous System Lymphoma Market.
  • Pembrolizumab is marketed under the trade name Keytruda by Novartis AG. It is used to treat intraocular melanoma as part of cancer immunotherapy, gently injected in the vein. The immune system can combat the cancer cells strengthened by it.    Pembrolizumab targets and blocks the activity of PD-1, a protein present on the surface of some immune cells called the T-cells.

Key Segments Profiled in the Central Nervous System Lymphoma Treatment industry Report:

Treatment:

  • Chemotherapy
  • Radiotherapy
  • Steroid therapy
  • Targeted therapy

End User:

  • Hospitals
  • Clinics
  • Ambulatory surgical centers

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pet Cancer Therapeutics Industry Poised for Significant Growth: Projected to Reach USD 898.6 Million by 2034

The global pet cancer therapeutics industry is set to experience extraordinary growth, with projections indicating a rise in sales from USD 400.9 million in 2024 to USD 898.6 million by 2034. This expansion reflects a robust compound annual growth rate (CAGR) of 8.4% over the forecast period from 2024 to 2034.

In 2023, the market generated USD 371.6 million in revenue, underscoring the increasing focus on addressing pet cancer—a critical issue driven by rising cancer incidence among pets. Contributing factors include genetic predisposition and environmental pollutants, which, akin to humans, have heightened the prevalence of cancer in companion animals.

The surge in market growth is also driven by greater awareness among pet owners and veterinarians. There is a growing recognition of the need for specialized and effective cancer treatments for pets, marking a significant evolution in veterinary medicine. This increased awareness is paving the way for advancements in therapeutic solutions tailored to the unique needs of companion animals.

“With the rise in pet cancer cases and increased awareness about effective treatment options, we are witnessing a pivotal moment in veterinary care,” said a from FMI. “Our focus remains on advancing therapeutic options that can significantly enhance the quality of life for pets battling cancer.”

As the pet cancer therapeutics industry continues to expand, stakeholders across the veterinary industry are poised to contribute to and benefit from this crucial growth, ensuring that pets receive the best possible care in their fight against cancer.

Key Takeaways: Pet Cancer Therapeutics Industry:

  • The global market for pet cancer therapeutics is expected to experience significant growth over the next decade, with sales increasing from USD 400.9 million in 2024 to USD 898.6 million by 2034.
  • This growth will be driven by a CAGR of 8.4% during the forecast period.
  • The USA dominates the North American market and is anticipated to maintain its leading position, with a projected CAGR of 9.1%.
  • China holds the largest share in the East Asia market and is expected to continue its growth trajectory, with a CAGR of 11.3%.
  • India is the dominant player in the South Asia & Pacific region, with a forecasted CAGR of 11.4%.

Dive into Pet Cancer Therapeutics Demand: Our Full Report Delivers In-Depth Trends and Insights!

Competitive Landscape:

Market players are deploying various strategies to maintain a competitive edge. These include differentiating their products through innovative formulations and forging strategic partnerships with healthcare providers for enhanced distribution. Companies are also focusing on finding strategic allies to strengthen their product portfolios and expand their global reach.

Recent Developments in the Pet Cancer Therapeutics Industry:

  • November 2023: Boehringer Ingelheim acquired Swiss biotech firm T3 Pharmaceuticals AG, with a potential payout of 450 million CHF. T3 Pharmaceuticals specializes in a unique therapy platform that uses live bacteria to deliver immune-modulating proteins to cancer cells and tumor microenvironments.
  • September 2023: Zoetis, a leading U.S.-based veterinary drug manufacturer, announced a definitive agreement to acquire Adivo. Adivo is a biotech company focused on developing therapeutic antibodies for companion animals.

Key Players of Pet Cancer Therapeutics Industry:

  • Zoetis Inc
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Virbac
  • Vetoquinol
  • Dechra Veterinary Products
  • Chemovet
  • AB Science
  • Nova Vive

Key Segments of Pet Cancer Therapeutics Industry:

By Drug Class:

In terms of drug class, the industry is divided into- chemotherapy drugs (doxorubicin (adriamycin), carboplatin, cisplatin, vincristine, lomustine (CCNU), cyclophosphamide, methotrexate, vinblastine, chlorambucil and other chemotherapy drugs). Nonsteroidal anti-inflammatory drugs (carprofen, meloxicam, other NSAIDs). Steroids- (prednisone, other steroid). Antiemetics- (ondansetron, other antiemetics). Monoclonal antibodies, immunomodulators, radiopharmaceuticals, tyrosine kinase inhibitors and bisphosphonates.

By Formulation:

In terms of formulation, the industry is segregated into injectable- (injectable solution, powder for injection). Oral- (tablet (regular), orally disintegrating tablets, capsule).

By Application:

In terms of application, the industry is segregated into cancer therapeutics, pain management and antiemetic therapeutics.

By Animal:

In terms of animal, the industry is segregated into dogs, cats and other animal.

By Cancer:

In terms of cancer, the industry is segregated into- lymphoma (lymphosarcoma), mast cell tumors, osteosarcoma and other cancer.

By Distribution Channel:

In terms of distribution channel, the industry is segregated into- institutional sales (specialty veterinary hospitals, veterinary clinics, veterinary oncology centers). Retail sales (compounding pharmacies, online veterinary pharmacies)

By Region:

Key countries of North America, Latin America, Western Europe, Eastern, South Asia, East Asia and Middle East and Africa (MEA) have been covered in the report.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

How to Raise Endurance in Bed Without Pills: Tips and Techniques

Having a gratifying and also satisfying sex life is something numerous individuals wish. One essential factor that can add to a satisfying sexual experience is stamina. Endurance refers to the ability to maintain sexual activity for a prolonged duration without feeling worn out or tired.

In today’s fast-paced globe, lots of people struggle with stamina concerns in bed. The good news is that there are all-natural and efficient methods to enhance endurance without depending on pills or medications. In this article, we will certainly check out different methods and also tips to help you boost your stamina and also enhance your sexual performance.

1. Focus On Physical Fitness and also Exercise

Normal workout plays a critical function in improving endurance in bed. Engaging in cardio workouts such as running, swimming, or biking aids improve total endurance and endurance. These activities enhance blood circulation, increase power levels, and improve cardiovascular health, every one of which are essential for a satisfying sex-related experience.

Including toughness training exercises like weightlifting or resistance training right into your physical fitness regimen can also boost endurance. Structure muscle mass toughness as well as endurance not just contributes to physical fitness however also help in keeping sex-related endurance.

Bear in mind to talk to a healthcare expert before starting any new workout routine, specifically if you have pre-existing clinical problems or issues.

2. Exercise Kegel Exercises

Kegel workouts are often connected with boosting urinary fumarex system control, however they likewise have a considerable impact on sex-related endurance. These exercises involve contracting and also relaxing the pelvic flooring muscular tissues, which are the muscles responsible for managing erections and also climaxing.

By on a regular basis exercising Kegel workouts, you can strengthen the pelvic flooring muscle mass, bring about much better control over erections and also delayed climaxing. This enhanced control can aid prolong sexual activity and also boost general stamina in bed.

To do Kegel workouts,:

  • Identify the appropriate muscular tissues by quiting peeing midstream. The muscular tissues you make use of to do this coincide ones you ought to be targeting throughout Kegel workouts.
  • Squeeze and hold these muscular tissues for a couple of seconds, then release. Beginning with a few repeatings and also progressively raise the duration and variety of reps with time.
  • Make Kegel exercises a component of your daily regimen for optimal results.

3. Preserve a Healthy And Balanced Diet Plan

Eating a nourishing and also well balanced diet plan is essential for general health and also well-being, including sex-related endurance. A healthy diet plan can offer the required vitamins, minerals, as well as nutrients that support sex-related feature as well as boost stamina.

Include foods that are rich in antioxidants, such as vegetables and fruits, to assist boost blood circulation. Foods high in Omega-3 fatty acids, like salmon and walnuts, can additionally enhance cardio health and wellness and also advertise endurance.

Additionally, take into consideration adding foods that are understood to have aphrodisiac residential properties to your diet. Instances consist of oysters, avocados, as well as dark delicious chocolate. While their performance might vary from one person to another, these foods have actually been generally connected with raised sex drive and sex-related efficiency.

4. Take Care Of Stress And Anxiety as well as Anxiousness

Anxiety as well as anxiety can substantially influence sex-related endurance. High levels of anxiety can bring about tiredness, psychological stress, and also decreased sex drive, making it challenging to do at your best in bed. For that reason, locating ways to manage as well as decrease anxiety levels is essential.

Taking part in stress-reducing tasks such as meditation, deep breathing exercises, or yoga can aid soothe your mind and advertise leisure. Focusing on self-care, getting enough rest, and keeping a healthy work-life balance are likewise crucial in taking care of tension as well as anxiety degrees.

Conclusion

Increasing stamina in bed without depending on pills is attainable through a combination of way of life modifications and healthy and balanced habits. Focusing on fitness, practicing Kegel exercises, keeping a healthy diet regimen, and managing stress and anxiety levels are all efficient techniques to enhance sexual endurance.

Keep in mind, it’s necessary to approach any modifications to your sex-related regular with patience acuflex and also open communication with your companion. Each person is special, and also what works for one person might not benefit one more. By applying these suggestions and also methods, you can take proactive steps in the direction of boosting your sexual stamina and also enjoying a more fulfilling sex life.

High Tibial Osteotomy Plates Leading the Way in Orthopedic Innovations: FMI Predicts Market to Surpass USD 355.9 million by 2033

In 2023, the global high tibial osteotomy plates industry is expected to be worth USD 235.91 million. The market is anticipated to expand at a 4.2% CAGR to reach USD 355.98 million by 2033.

The increasing prevalence of osteoarthritis and other musculoskeletal conditions among the aging population is driving the demand for high tibial osteotomy plates. These plates are used in surgical procedures to correct alignment issues in the knee joint, providing relief to patients suffering from knee pain and discomfort.

Advancements in surgical techniques and technologies are allowing for precise and effective high-tibial osteotomy procedures, further driving market growth.

Despite the positive growth drivers, the high tibial osteotomy plates industry also faces certain restraints. One key restraint is the high cost associated with the surgical procedure and the materials used in high tibial osteotomy plates. The cost of these plates and the overall surgical procedure can be a barrier for patients, particularly in developing regions with limited healthcare resources and affordability.

Strict regulations and approval processes for medical devices, including high tibial osteotomy plates, may also pose challenges for manufacturers and limit the market growth.

The high tibial osteotomy plates industry presents several growth opportunities. One significant opportunity is the increasing adoption of minimally invasive surgical techniques, such as arthroscopy-assisted high tibial osteotomy, which offers fast recovery, few complications, and better patient outcomes.

The growing demand for personalized and patient-specific high tibial osteotomy plates, made using advanced 3D printing and computer-aided design (CAD) technologies, presents opportunities for customization and innovation in the industry.

The high tibial osteotomy plates industry is witnessing several latest trends that are shaping the market. One prominent trend is the increasing use of bioabsorbable materials in high tibial osteotomy plates. Bioabsorbable plates offer advantages such as the reduced risk of implant-related complications, improved bone healing, and elimination of the need for implant removal surgeries.

Another emerging trend is the integration of digital technologies, such as navigation systems, robotics, and augmented reality, into high-tibial osteotomy procedures for improved accuracy, precision, and patient outcomes.

Key Takeaways from the High Tibial Osteotomy Plates industry:

  • In 2022, the United States accounted for almost 40% of the market for high tibial osteotomy plates, taking the lead position.
  • In 2022, Germany held a notable share of about 20% in the high tibial osteotomy plates sector.
  • In 2022, China is predicted to have a key market share of nearly 30% in the high tibial osteotomy plates sector.
  • In 2022, Japan had a considerable market share of roughly 15% in the high tibial osteotomy plates sector.
  • The open-wedge technique segment dominates the high tibial osteotomy plates industry, accounting for 53% of the overall market share in 2022.
  • The metal segment dominates the high tibial osteotomy plate market, which is estimated to reach USD 322.2 million by 2033.
  • The hospital segment dominates the high tibial osteotomy plates industry as hospitals are equipped with modern medical technology and give better surgical outcomes for patients.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Outshining the Competition: High Tibial Osteotomy Plates Industry Players in the Spotlight:

The high tibial osteotomy plates industry is characterized by robust competition with several key players vying for market share. These companies employ various strategies to stay at the top of the market and cater to the growing demand for high-quality medical devices.

The companies have a strong presence in the global market and are known for their technologically advanced products, extensive distribution networks, and established customer base. They invest hugely in research and development to continuously innovate and launch new products to stay ahead of the competition.

With the growing demand for high tibial osteotomy plates, several new entrants are entering the market with innovative products and technologies. These companies are leveraging their expertise in materials science, biomechanics, and medical technology to disrupt the market and gain market share. While they may face challenges in establishing their brand presence and distribution networks, they bring fresh perspectives and innovative solutions to the industry.

The high tibial osteotomy plates industry also faces challenges, including stringent regulatory requirements, increasing competition, and pricing pressures. Companies need to comply with various regulatory standards, such as FDA approvals and ISO certifications.

Recent Developments in the Market:

  • Smith & Nephew Plc. announced in January 2021 that it had successfully paid $ 240 million for Integra LifeSciences Holdings Corporation’s extremities orthopedics division.
  • Olympus Corporation bought GROUPE FH ORTHO in November 2020. By extending the distribution of both Olympus’ orthopedic goods through GROUPE FH ORTHO’s current distribution channels and particular products in Japan, the purchase of GROUPE FH ORTHO boosted the sales channels.

Key Players in the High Tibial Osteotomy Plates Industry:

  • Arthrex, Inc.
  • DePuy Synthes (a Johnson & Johnson company)
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • CONMED Corporation
  • Wright Medical Group N.V.

Global High Tibial Osteotomy Plates industry by Category:

By Technique:

  • Open-wedge technique
  • Closed-wedge technique
  • Progressive callus distraction
  • Chevron osteotomy
  • Dome technique

By Material:

  • Metal
  • Polymer

By End-use:

  • Hospitals
  • Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Finding the Best Online Casino Gambling Sites

There are a variety of facto icecasinors you should consider when searching for the top casinos online. There are hundreds upon hundreds of websites that claim to provide the best entertainment and many of them claim to have the top online casinos. You need to know which sites offer the most enjoyable entertainment. Here are some important tips to help make the right choice and locate the perfect online casino for you.

payout percentages payout percentages: One of the main things to watch for is how payout percentages are done at different casinos. If an online gambling site claims to give you 100% payout probabilities, make sure you know br ice cassino the reason for this. Many casinos will boast about their percentages of winnings if their software for casinos allows it. This means that all the winnings that were gained through the games played back at the casino are refunded in full!

Protection from bankruptcy: While it might seem unlikely, find out what the casino offers in terms of bankruptcy protection. There are a lot of online gambling casinos which do not provide any type of bankruptcy protection. When this happens, you could be left with no money since you don’t have any form of payment method when you are due to get your winnings. While you can withdraw your winnings from casinos, there’s no way to pay the winners. It is important to compare this with the more secure payment methods like PayPal that you can use to transfer money to your winners and to pay out your winnings.

Customer support: While many online casinos will offer free customer support, it is crucial to ensure that you do not have to wait for hours to receive responses to your questions. Also, make sure that you are able to reach customer support promptly time. It is crucial that you have access to the customer service on a website. If you are not able to do so contact them using your email address. This will guarantee that you get faster responses. The best casinos will be quick to respond to your questions and keep you informed of the most recent developments in their casinos and games.

There are a variety of games to choose from: Many online casino games come with various payout percentages. This is important to ensure that you pick the games you like the most and that you can make a profit. For instance, some casinos on the internet will pay of just pennies per bet. These are low payouts, however when you’re just beginning your journey at casinos online, this might not be a problem. Other casinos online may employ multiple systems to determine the payouts. This could include e-mails and text message alerts that inform customers of their payouts once they have been received.

Welcome bonuses: Some casinos provide new players free money as an incentive to sign up. This can be used towards depositing real cash, so you do not have to redeem your welcome bonus at any time. You will be informed in the same way as you would receive a email or text message alerts in the event that the bonus money is used.

Online gaming casinos all offer a bovada casino deposit option. They also provide an online casino experience in which you can play games for free until you receive your deposit or until your account reaches an amount that you specify. With this feature, you can get to experience the thrill of gambling while safeguarding your money while also protecting your funds.

To find the top casinos online that allow you to have the most enjoyable online casino experience, take your time and compare each casino carefully. Don’t rush into signing up with the first casino site online you come across. Instead, take some time to make sure you’re making the right choice for your gaming needs. This way, you will be able to enjoy your gambling experience and stay within your budget.

Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Industry to Witness Robust Growth is projected to reach USD 89.6 million by 2034 Amid Rising Awareness and Technological Advancements | FMI

The global ESR1 mutated metastatic breast cancer diagnostics industry is poised for significant expansion, with an anticipated year-over-year (y-o-y) growth rate of 4.0%. The market size is projected to grow from USD 63.4 million in 2024 to USD 89.6 million by 2034, reflecting a compound annual growth rate (CAGR) of 3.7% during the forecast period.

Accounting for approximately 0.9% of the global breast cancer diagnostics industry in 2024, the ESR1 mutated metastatic breast cancer diagnostics sector is set to gain prominence as demand surges,

Driven By Several Key Factors:

  • Rising prevalence of metastatic breast cancer worldwide.
  • Growing awareness about metastatic breast cancer testing and the benefits of early detection.
  • Increased adoption of precision diagnostics for enhanced cancer detection and treatment planning.
  • Advancements in ESR1 gene mutation diagnostics, bolstered by ongoing research and innovation.
  • Expansion of breast cancer awareness programs globally, highlighting the importance of advanced diagnostic tools.

Market Trends Shaping the Future of ESR1 Diagnostics

Emerging trends in the ESR1 mutated metastatic breast cancer diagnostics industry are expected to further propel its growth:

  1. Advances in breast cancer mutation diagnostics – The need for more accurate and reliable diagnostic tools is driving innovation in ESR1-related tests.
  2. Rising popularity of biomarker testing – Biomarkers are becoming crucial in identifying and treating specific cancer subtypes.
  3. Shift towards personalized medicine – The growing emphasis on precision medicine underscores the importance of ESR1 testing in tailoring treatment strategies.
  4. Preference for liquid biopsies – Liquid biopsies are gaining traction as a non-invasive, efficient method for cancer detection.
  5. Ongoing advancements in molecular diagnostics – Cutting-edge technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR) are revolutionizing the diagnostic landscape.

Future Outlook:

As the healthcare industry continues to prioritize precision medicine and personalized care, the ESR1 mutated metastatic breast cancer diagnostics industry is expected to play a pivotal role in improving patient outcomes. Increased awareness, technological advancements, and robust research initiatives are set to fuel market growth and reshape the global breast cancer diagnostics industry.

Expanding Market Need: Access Our Full Report for In-Depth Analysis and Trends!

Key Takeaways: Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Industry:

  1. Market Growth Overview:
    • The global ESR1 mutated metastatic breast cancer diagnostics market is projected to grow from USD 63.4 million in 2024 to USD 89.6 million by 2034, with a compound annual growth rate (CAGR) of 3.7% during the forecast period.
    • The market is expected to achieve a year-over-year (y-o-y) growth rate of 4.0%.
  2. Regional Growth Insights:
    • United States: Forecasted to grow at a Value CAGR of 1.7% from 2024 to 2034.
    • Germany: Expected to expand at a Value CAGR of 1.6% over the same period.
    • United Kingdom: Poised for growth at a Value CAGR of 2.1%.
    • Japan: Projected to grow significantly with a Value CAGR of 3.3%.
    • China: Leading regional growth with a Value CAGR of 7.2%.
    • Spain: Expected to expand at a Value CAGR of 2.7%.

This robust growth trajectory underscores the increasing focus on advanced diagnostics for metastatic breast cancer globally, with notable regional variations in market expansion rates.

Competitive Landscape:

Key players in the ESR1 mutated metastatic breast cancer diagnostics are Berlin-Chemie, Pfizer, Sanofi, G1 Therapeutics, Inc., Sun Pharma Advanced Research Company, Zenopharm, Arvinas, Sermonix Pharmaceuticals, Roche, AstraZeneca, Novartis, Zentalis Pharmaceuticals, Olema Pharmaceuticals

  • Sanofi has developed a targeted therapy called SAR439859, which is currently being evaluated in clinical trials for the treatment of advanced breast cancer, including ESR1 mutated metastatic breast cancer. SAR439859 is an oral selective estrogen receptor degrader (SERD) that works by blocking the activity of the estrogen receptor (ER) protein, which is often overexpressed in breast cancer cells. The drug has shown promising results in preclinical studies, and it is currently being evaluated in several clinical trials to assess its safety and efficacy in breast cancer patients.
  • G1 Therapeutics has been involved in the development of diagnostic tools to identify ESR1 mutations in breast cancer patients. In 2021, the company announced that it had entered into a collaboration with Guardant Health, a leading precision oncology company, to develop a liquid biopsy test for the detection of ESR1 mutations in circulating tumor DNA (ctDNA) from breast cancer patients.

Key Segments Profiled in the ESR1 Mutated Metastatic Breast Cancer Diagnostics Industry Survey

Hormonal therapy:

  • Tamoxifen
  • Aromatase inhibitors
  • Ovarian suppression
  • Fulvestrant
  • Elacestrant

Chemotherapy:

  • Capecitabine
  • Carboplatin
  • Cisplatin
  • Cyclophosphamide
  • Docetaxel
  • Others

Targeted therapy:

  • Monoclonal antibodies
  • Small molecule inhibitors
  • Tumor-agnostic treatments
  • Immunotherapy
  • Pembrolizumab
  • Dostarlimab

End User:

  • Hospitals
  • Clinics
  • Research and Academic Institutes
  • Diagnostic Centres

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube